Taurine 11 pp 935-947 | Cite as

The microRNAs Expression Profile in Sciatic Nerves of Diabetic Neuropathy Rats After Taurine Treatment by Sequencing

  • Xiaoxia Shi
  • Zewen Qiu
  • Inam-u-llah
  • Mengren Zhang
  • Kaixin Li
  • Pingan Wu
  • Raheel Suleman
  • Rana Muhammad Aadil
  • Fengyuan Piao
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1155)


Taurine protect against diabetic neuropathy. However, the protective mechanism of taurine has been poorly understood. It has been demonstrated that microRNAs (miRNAs) are involved in regulating gene expression. Therefore, it is interested in whether taurine affects miRNAs expression profile in peripheral nerve tissue of diabetic neuropathy. In the present study, rats were treated as three group: (1) control (Con) group, (2) diabetic mellitus (DM) group and (3) taurine treatment (Tau) group. Sciatic nerve tissue was harvested and miRNA expression was determined using sequencing. The results showed that 80 miRNAs showed significant difference in DM group compared to Con group, of which 20 miRNAs showed up-regulating, as well as, 60 miRNAs showed down-regulating. On the other hand, 215 differential miRNAs were found between DM and Tau groups. Moreover, the numbers of up-regulated and down-regulated miRNAs were 1 and 214, respectively. Twelve specific miRNAs were screened out and the target genes were obtained by target analysis software. GO and KEGG enrichment analyses showed that these potential target genes for the miRNAs might be involved in axon guidance, generation of neurons, nervous system development and neurogenesis. Our results provided a miRNA profile for further exploring protective mechanisms of taurine against diabetic peripheral neuropathy.


Taurine MicroRNA Diabetic neuropathy Sequencing 



Diabetes mellitus


diabetic peripheral neuropathy


quantitative real time PCR


  1. Aghdaei FH, Soltani BM, Dokanehiifard S, Mowla SJ, Soleimani M (2017) Overexpression of hsa-miR-939 follows by NGFR down-regulation and apoptosis reduction. J Biosci 42:23–30CrossRefGoogle Scholar
  2. Anuradha CV, Balakrishnan SD (1999) Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77:749–754CrossRefGoogle Scholar
  3. Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973–1988CrossRefGoogle Scholar
  4. Chen W, Guo J, Zhang Y, Zhang J (2016) The beneficial effects of taurine in preventing metabolic syndrome. Food Funct 7:1849–1863CrossRefGoogle Scholar
  5. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817–824CrossRefGoogle Scholar
  6. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1–34CrossRefGoogle Scholar
  7. Feng Y, Chen L, Luo Q, Wu M, Chen Y et al (2018) Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des Devel Ther 12:171–177CrossRefGoogle Scholar
  8. Franconi F, Di Leo MAS, Bennardini F, Ghirlanda G (2004) Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 29:143–150CrossRefGoogle Scholar
  9. Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH (2010) Measuring nerve regeneration in the mouse. Exp Neurol 223:60–71CrossRefGoogle Scholar
  10. Hutchison ER, Okun E, Mattson MP (2009) The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair. NeuroMolecular Med 11:153–161CrossRefGoogle Scholar
  11. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163CrossRefGoogle Scholar
  12. IDF International Diabetes Federation Diabetes Atlas (2013) International Diabetes Federation, 6th edn, BrusselsGoogle Scholar
  13. Imae M, Asano T, Murakami S (2014) Potential role of taurine in the prevention of diabetes and metabolic syndrome. Amino Acids 46:81–88CrossRefGoogle Scholar
  14. Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529–1539CrossRefGoogle Scholar
  15. Kendler BS (1989) Taurine: an overview of its role in preventive medicine. Prev Med 18:79–100CrossRefGoogle Scholar
  16. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20CrossRefGoogle Scholar
  17. Li F, Obrosova IG, Abatan O, Tian D, Larkin D, Stuenkel EL (2005) Stevens MJ. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288:E29–E36CrossRefGoogle Scholar
  18. Li F, Abatan OI, Kim H, Burnett D, Larkin D et al (2006a) Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 22:669–676CrossRefGoogle Scholar
  19. Li Y, Wang F, Lee JA, Gao FB (2006b) MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. FBGenes Dev 20:2793–2805CrossRefGoogle Scholar
  20. Sarkar P, Basak P, Ghosh S, Kundu M, Sil PC (2017) Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. Food Chem Toxicol 110:109–121CrossRefGoogle Scholar
  21. Schulte JH, Marschall T, Martin M, Rosenstiel P, Mestdagh P et al (2010) Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res 38:5919–5928CrossRefGoogle Scholar
  22. Sima AA, Sugimoto K (1999) Experimental diabetic neuropathy: an update. Diabetologia 42:773–788CrossRefGoogle Scholar
  23. Sinnreich M, Taylor BV, Dyck PJ (2005) Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 11:63–79CrossRefGoogle Scholar
  24. Sirdah MM (2015) Protective and therapeutic effectiveness of taurine in diabetes mellitus: a rationale for antioxidant supplementation. Diabetes Metab Syndr 9:55–64CrossRefGoogle Scholar
  25. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA et al (1993) Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36:608–614CrossRefGoogle Scholar
  26. Tappaz M, Almarghini K, Legay F, Remy A (1992) Taurine biosynthesis enzyme cysteine sulfinate decarboxylase (CSD) from brain: the long and tricky trail to identification. Neurochem Res 17:849–859CrossRefGoogle Scholar
  27. Vinik AI, Park TS, Stansberry KB, Pittenger GL (2000) Diabetic neuropathies. Diabetologia 43:957–973CrossRefGoogle Scholar
  28. Wang H, Ye Y, Zhu Z, Mo L, Lin C et al (2016) MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson’s disease by targeting to Bim. Brain Pathol 26:167–176CrossRefGoogle Scholar
  29. Zou H, Ding Y, Wang K, Xiong E, Peng W et al (2015) MicroRNA-29A/PTEN pathway modulates neurite outgrowth in PC12 cells. Neuroscience 291:289–300CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Xiaoxia Shi
    • 1
  • Zewen Qiu
    • 2
  • Inam-u-llah
    • 1
  • Mengren Zhang
    • 1
  • Kaixin Li
    • 1
  • Pingan Wu
    • 1
  • Raheel Suleman
    • 3
  • Rana Muhammad Aadil
    • 4
  • Fengyuan Piao
    • 1
  1. 1.Department of Occupational and Environmental HealthDalian Medical UniversityDalianChina
  2. 2.Laboratory Animal CenterDalian Medical UniversityDalianChina
  3. 3.Institute of Food Science and TechnologyGraduate School of Chinese Academy of Agriculture ScienceBeijingChina
  4. 4.National Institute of Food Science and TechnologyUniversity of Agriculture FaisalabadFaisalabadPakistan

Personalised recommendations